643 related articles for article (PubMed ID: 16513106)
1. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
2. The effect of a Titanocene Dichloride derivative, Ti IV (C5H5)(2) NCS(2), on the haematopoietic response of Ehrlich tumour-bearing mice.
Valadares MC; Queiroz ML
Eur J Pharmacol; 2002 Mar; 439(1-3):35-42. PubMed ID: 11937090
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
Köpf-Maier P
Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
[TBL] [Abstract][Full Text] [Related]
4. Titanocene modulation of cytokine imbalance induced by Ehrlich ascites tumour progression.
Valadares MC; Klein SI; Queiroz ML
Eur J Pharmacol; 2004 Oct; 503(1-3):203-8. PubMed ID: 15496315
[TBL] [Abstract][Full Text] [Related]
5. Euphorbia tirucalli L. modulates myelopoiesis and enhances the resistance of tumour-bearing mice.
Valadares MC; Carrucha SG; Accorsi W; Queiroz ML
Int Immunopharmacol; 2006 Feb; 6(2):294-9. PubMed ID: 16399635
[TBL] [Abstract][Full Text] [Related]
6. Chlorella vulgaris modulates immunomyelopoietic activity and enhances the resistance of tumor-bearing mice.
Ramos AL; Torello CO; Queiroz ML
Nutr Cancer; 2010; 62(8):1170-80. PubMed ID: 21058206
[TBL] [Abstract][Full Text] [Related]
7. In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenes.
Kelter G; Sweeney NJ; Strohfeldt K; Fiebig HH; Tacke M
Anticancer Drugs; 2005 Nov; 16(10):1091-8. PubMed ID: 16222151
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative activity of Titanocene Y against tumor colony-forming units.
Oberschmidt O; Hanauske AR; Pampillón C; Sweeney NJ; Strohfeldt K; Tacke M
Anticancer Drugs; 2007 Mar; 18(3):317-21. PubMed ID: 17264765
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
Da Silva SL; Chaar Jda S; Yano T
Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
[TBL] [Abstract][Full Text] [Related]
10. Methoxy-phenyl substituted ansa-titanocenes as potential anti-cancer drugs derived from fulvenes and titanium dichloride.
Tacke M; Cuffe LP; Gallagher WM; Lou Y; Mendoza O; Müller-Bunz H; Rehmann FJ; Sweeney N
J Inorg Biochem; 2004 Dec; 98(12):1987-94. PubMed ID: 15541486
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice.
Beckhove P; Oberschmidt O; Hanauske AR; Pampillón C; Schirrmacher V; Sweeney NJ; Strohfeldt K; Tacke M
Anticancer Drugs; 2007 Mar; 18(3):311-5. PubMed ID: 17264764
[TBL] [Abstract][Full Text] [Related]
12. Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives.
Abeysinghe PM; Harding MM
Dalton Trans; 2007 Aug; (32):3474-82. PubMed ID: 17680034
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of natural killer cell function by titanocenes in mice bearing Ehrlich ascites tumour.
Valadares MC; Klein SI; Guaraldo AM; Queiroz ML
Eur J Pharmacol; 2003 Jul; 473(2-3):191-6. PubMed ID: 12892838
[TBL] [Abstract][Full Text] [Related]
14. Antitumor metallocenes: new developments and toxicologic features.
Köpf-Maier P; Köpf H
Anticancer Res; 1986; 6(2):227-33. PubMed ID: 3707060
[TBL] [Abstract][Full Text] [Related]
15. Comparative investigation of the effect of ukrain on growth of ascites and solid forms of Ehrlich's carcinoma.
Susak YM; Skivka LM; Rudik MP; Pozur VV; Liubunya AV
Exp Oncol; 2010 Jul; 32(2):107-10. PubMed ID: 20693973
[TBL] [Abstract][Full Text] [Related]
16. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice.
Sheeja K; Kuttan G
Integr Cancer Ther; 2007 Mar; 6(1):66-73. PubMed ID: 17351028
[TBL] [Abstract][Full Text] [Related]
17. Immunologic response to the treatment of Ehrlich ascites tumor with titanocene dichloride.
Köpf-Maier P; Hesse A
J Cancer Res Clin Oncol; 1984; 108(2):254-5. PubMed ID: 6540782
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of a new mixed-ligand complex di-n-butyl-(4-chlorobenzohydroxamato)tin(IV) chloride.
Li Y; Li Y; Niu X; Jie L; Shang X; Guo J; Li Q
J Inorg Biochem; 2008 Sep; 102(9):1731-5. PubMed ID: 18573534
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs.
Gómez-Ruiz S; Kaluderović GN; Prashar S; Polo-Cerón D; Fajardo M; Zizak Z; Sabo TJ; Juranić ZD
J Inorg Biochem; 2008 Aug; 102(8):1558-70. PubMed ID: 18353439
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
Yamamoto N; Naraparaju VR
Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
